Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease

被引:174
作者
Meredith, GE
Totterdell, S
Petroske, E
Cruz, KS
Callison, RC
Lau, YS
机构
[1] Finch Univ Hlth Sci Chicago Med Sch, Dept Mol & Cellular Pharmacol, N Chicago, IL 60064 USA
[2] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
[3] Univ Missouri, Sch Pharm, Dept Pharmacol, Kansas City, MO 64108 USA
[4] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA
[5] Univ Kansas, Ctr Med, Dept Surg Pathol, Kansas City, KS USA
关键词
inclusion body; Lewy body; ubiquitin; lipofuscin; MPTP; probenecid;
D O I
10.1016/S0006-8993(02)03514-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have detected granular and filamentous inclusions that are alpha-synuclein- and ubiquitin-immunoreactive in the cytoplasm of dopaminergic and cortical neurons of C57/black mice treated chronically with 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) and probenecid. The immunoreactive aggregates only become evident several weeks after large-scale dopaminergic cell death and a downregulation of alpha-synuclein gene expression. Numerous lipofuscin granules accumulate (x-synuclein in the nigral and limbic cortical neurons of treated mice. These data provide evidence that insoluble proteins, such as a-synuclein, build up as granular and filamentous inclusions in dopaminergic neurons that survive the initial toxic MPTP insult. They further suggest that defective protein degradation rather than altered gene expression underlies deposition of a-synuclein and that abundant lysosomal compartments are present to seal off the potentially toxic material. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:156 / 165
页数:10
相关论文
共 57 条
[41]   The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity [J].
Ostrerova-Golts, N ;
Petrucelli, L ;
Hardy, J ;
Lee, JM ;
Farer, M ;
Wolozin, B .
JOURNAL OF NEUROSCIENCE, 2000, 20 (16) :6048-6054
[42]   Developmental expression of α-synuclein in rat hippocampus and cerebral cortex [J].
Petersen, K ;
Olesen, OF ;
Mikkelsen, JD .
NEUROSCIENCE, 1999, 91 (02) :651-659
[43]   Mouse model of Parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment [J].
Petroske, E ;
Meredith, GE ;
Callen, S ;
Totterdell, S ;
Lau, YS .
NEUROSCIENCE, 2001, 106 (03) :589-601
[44]   Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease [J].
Przedborski, S ;
Chen, QP ;
Vila, M ;
Giasson, BI ;
Djaldatti, R ;
Vukosavic, S ;
Souza, JM ;
Jackson-Lewis, V ;
Lee, VMY ;
Ischiropoulos, H .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (02) :637-640
[45]   ULTRASTRUCTURAL OBSERVATIONS IN PARKINSONISM [J].
ROY, S ;
WOLMAN, L .
JOURNAL OF PATHOLOGY, 1969, 99 (01) :39-+
[46]   Induction of neuronal death by α-synuclein [J].
Saha, AR ;
Ninkina, NN ;
Hanger, DP ;
Anderton, BH ;
Davies, AM ;
Buchman, VL .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (08) :3073-3077
[47]   SELECTIVE LOSS OF SUBPOPULATIONS OF VENTRAL MESENCEPHALIC DOPAMINERGIC-NEURONS IN THE MONKEY FOLLOWING EXPOSURE TO MPTP [J].
SCHNEIDER, JS ;
YUWILER, A ;
MARKHAM, CH .
BRAIN RESEARCH, 1987, 411 (01) :144-150
[48]   DOSE-DEPENDENT DESTRUCTION OF THE COERULEUS-CORTICAL AND NIGRAL-STRIATAL PROJECTIONS BY MPTP [J].
SENIUK, NA ;
TATTON, WG ;
GREENWOOD, CE .
BRAIN RESEARCH, 1990, 527 (01) :7-20
[49]  
SOHAL RS, 1990, LIPOFUSCIN CEROID PI, P17
[50]   alpha-synuclein in Lewy bodies [J].
Spillantini, MG ;
Schmidt, ML ;
Lee, VMY ;
Trojanowski, JQ ;
Jakes, R ;
Goedert, M .
NATURE, 1997, 388 (6645) :839-840